Overview
- The collaboration between OpenAI, PerturbAI and Scripps Research announced the result Wednesday after running roughly 2,000 coordinated AI agents on OpenAI’s life-sciences model GPT-Rosalind to analyze PerturbAI’s CRISPR atlas.
- The agents processed the atlas in 32 minutes and produced a searchable reasoning atlas that ties each gene disruption to changes in cell activity and supporting scientific papers.
- Compared with a single-agent run, the multi-agent approach returned more than 700 literature citations versus 11 and was preferred by blinded experts in 75 percent of comparisons.
- The system generated testable leads, including a possible link between DCTN1 disruption and increased neuronal cholesterol production relevant to Perry syndrome and unexpected differences between Tsc1 and Tsc2 effects in the cerebellum.
- The team posted a bioRxiv preprint and made the atlas public but emphasized that these findings are computational leads that need peer review and experimental follow-up before they can guide drug discovery or clinical claims.